Literature DB >> 10981121

Xenobiotics, dietary interventions, and genetically mediated therapies.

N J Schork1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10981121     DOI： 10.1007/s11906-000-0051-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  6 in total

Review 1.  Nutriceuticals for cardiovascular health.

Authors:  J P Cooke
Journal:  Am J Cardiol       Date:  1998-11-19       Impact factor: 2.778

Review 2.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation.

Authors:  F J Gonzalez; D W Nebert
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

3.  Functional foods.

Authors:  D R Farr
Journal:  Cancer Lett       Date:  1997-03-19       Impact factor: 8.679

4.  Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene.

Authors:  S C Hunt; J M Geleijnse; L L Wu; J C Witteman; R R Williams; D E Grobbee
Journal:  Am J Hypertens       Date:  1999-05       Impact factor: 2.689

Review 5.  Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance.

Authors:  A Puga; D W Nebert; R A McKinnon; A G Menon
Journal:  Crit Rev Toxicol       Date:  1997-03       Impact factor: 5.635

6.  Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

Authors:  S C Hunt; N R Cook; A Oberman; J A Cutler; C H Hennekens; P S Allender; W G Walker; P K Whelton; R R Williams
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.